Search clinical trials for: ProAir Digihaler

Total 35 results

University of North Carolina, Chapel Hill
Wake Forest University Health Sciences; Teva Branded Pharmaceutical Products...

Completed

Digihaler in Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States
University of Michigan
Teva Branded Pharmaceutical Products R&D, Inc.

Active, not recruiting

Teva Asthma Predictive Analytics Study

Asthma

United States
Pulmonary Research Institute of Southeast Michigan
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

ProAir Digihaler in COPD Disease Management: A Real World Study

COPD | COPD Exacerbation Acute

United States
Franciscus Gasthuis
Teva Pharmaceuticals USA

Recruiting

Expertise Asthma COPD Program With Digital Support (EXACT@home)

Asthma

Netherlands
Intech Biopharm Ltd.

Recruiting

Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

Mild Asthma

Taiwan, India
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype

Primary Ciliary Dyskinesia

United States
University of Florida

Recruiting

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

Alpha-1 Antitrypsin Deficiency | Cystic Fibrosis (CF) | AATD | AAT Deficiency

United States
Organon and Co

Completed

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

Chronic Asthma
University of California, San Francisco
Flight Attendant Medical Research Institute

Active, not recruiting

Secondhand Smoke Respiratory Health Study

Hyperinflation | Tobacco | Obstructive Lung Disease | Secondhand Smoke | Air Trapping | Airflow Limitation

United States
Intech Biopharm Ltd.

Completed

Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

Healthy

Taiwan
Intech Biopharm Ltd.

Completed

Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108 mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions

Healthy

Taiwan
Children's Hospital Los Angeles
Teva Pharmaceuticals USA

Completed

Albuterol Integrated Adherence Monitoring in Children With Asthma

Asthma in Children

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Albuterol HFA MDI in Pediatric Participants With Asthma

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Persistent Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics

Asthma

United States, Thailand
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma

Persistent Asthma

United States
Amphastar Pharmaceuticals, Inc.

Completed

Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals

Asthma | Pharmacokinetics | Anaphylaxis | Epinephrine | Albuterol

United States
Sun Pharmaceutical Industries Limited

Completed

A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)

Asthma

United States
Lupin, Inc.

Completed

Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma

Mild Persistent Asthma

United States
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)

Rhinitis, Allergic, Seasonal
Oregon Health and Science University

Completed

Preterm Infant Inhaled Albuterol Dosing

Bronchopulmonary Dysplasia | Very Low Birth Weight

United States
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial (BEAT HFpEF)

Congestive Heart Failure | Left-Sided Heart Failure | Heart Failure, Left-Sided

United States
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) (TREXA)

Asthma

United States
Northwell Health
AstraZeneca; Jacobi Medical Center; Nassau University Medical Center

Completed

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety Study of Albuterol Spiromax® in Subjects With Asthma

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)

Exercise-Induced Bronchoconstriction (EIB)

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma

Asthma

United States

3

Subscribe